Insider · CIK 1723524
Darren Sherman
- Director at Orchestra BioMed Holdings OBIO: 2 buys, 11 sales
- Director at Motus GI Holdings MOTS: 4 buys, 0 sales
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Open-market buys6
Open-market sales11
Bought$252K
Sold$634K
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Nov 2, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $5.74 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. | $86K | 1,104,402 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Oct 1, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $6.36 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. | $95K | 1,119,402 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. |
| Sep 1, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $4.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 1, 2026. | $74K | 1,134,402 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 1, 2026. |
| Aug 26, 2026 | Orchestra BioMed Holdings OBIO | Bought 2,000 sh at $5.33 Their first shares, by the holdings the Form 4 states. 16 days after the company's 10-Q filed Aug 10, 2026. | $11K | 2,000 | Their first shares, by the holdings the Form 4 states. 16 days after the company's 10-Q filed Aug 10, 2026. |
| Aug 3, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $4.09 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 3, 2026. | $61K | 1,154,327 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 3, 2026. |
| Jul 1, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $4.27 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2026. | $64K | 1,169,327 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2026. |
| Jun 1, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $3.87 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. | $58K | 1,184,327 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. |
| Aug 25, 2025 | Orchestra BioMed Holdings OBIO | Bought 3,000 sh at $2.62 Their first open-market buy here in SEC Tracker's records. One of 3 insiders who bought $83K over 22 days, within the 30-day window. 13 days after the company's 10-Q filed Aug 12, 2025. | $8K | 926,837 +<1% | Their first open-market buy here in SEC Tracker's records. One of 3 insiders who bought $83K over 22 days, within the 30-day window. 13 days after the company's 10-Q filed Aug 12, 2025. |
| Sep 10, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,904 sh at $5.31 The filing does not mark this sale as under a Rule 10b5-1 plan. 82 days after the company's 8-K filed Jun 20, 2024. | $37K | 765,787 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 82 days after the company's 8-K filed Jun 20, 2024. |
| Sep 9, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,804 sh at $5.48 The filing does not mark this sale as under a Rule 10b5-1 plan. 81 days after the company's 8-K filed Jun 20, 2024. | $37K | 772,691 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 81 days after the company's 8-K filed Jun 20, 2024. |
| Sep 6, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,819 sh at $5.65 The filing does not mark this sale as under a Rule 10b5-1 plan. 78 days after the company's 8-K filed Jun 20, 2024. | $39K | 779,495 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 78 days after the company's 8-K filed Jun 20, 2024. |
| Sep 5, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,961 sh at $5.85 The filing does not mark this sale as under a Rule 10b5-1 plan. 77 days after the company's 8-K filed Jun 20, 2024. | $41K | 786,314 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 77 days after the company's 8-K filed Jun 20, 2024. |
| Sep 4, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,837 sh at $6.10 The filing does not mark this sale as under a Rule 10b5-1 plan. 76 days after the company's 8-K filed Jun 20, 2024. | $42K | 793,275 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 76 days after the company's 8-K filed Jun 20, 2024. |
| Dec 17, 2020 | Motus GI Holdings MOTS | Bought 3,000 sh at $0.97 | $3K | 42,746 +8% | |
| May 17, 2018 | Motus GI Holdings MOTS | Bought 1,000 sh at $5.55 | $6K | 9,000 +13% | |
| Feb 16, 2018 | Motus GI Holdings MOTS | Bought 45,000 sh at $5.00 Their first open-market buy here in SEC Tracker's records. One of 3 insiders who bought $810K over 1 day, within the 30-day window. | $225K | Their first open-market buy here in SEC Tracker's records. One of 3 insiders who bought $810K over 1 day, within the 30-day window. |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.
Data on this page was fetched . The filing on SEC.gov is the record.